200,000+ products from a single source!
sales@angenechem.com
23642-66-2 | Ethanol, 2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]-, 1-benzoate, hydrochloride (1:1)
CAS No: 23642-66-2 Catalog No: AG002O0S MDL No:MFCD00058493
Product Description
Catalog Number:
AG002O0S
Chemical Name:
Ethanol, 2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]-, 1-benzoate, hydrochloride (1:1)
CAS Number:
23642-66-2
Molecular Formula:
C19H21ClF3NO2
Molecular Weight:
387.8237
MDL Number:
MFCD00058493
IUPAC Name:
2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl benzoate;hydrochloride
InChI:
InChI=1S/C19H20F3NO2.ClH/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16;/h2-9,13-14,23H,10-12H2,1H3;1H
InChI Key:
NLOALSPYZIIXEO-UHFFFAOYSA-N
SMILES:
CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c1ccccc1.Cl
EC Number:
245-801-8
NSC Number:
757396
Properties
Complexity:
408
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
387.121g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
387.827g/mol
Monoisotopic Mass:
387.121g/mol
Rotatable Bond Count:
8
Topological Polar Surface Area:
38.3A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Pulmonary hypertension associated with benfluorex exposure. | The European respiratory journal 20121101 |
| Can benfluorex induce congenital malformations? | Diabetes & metabolism 20121001 |
| Top adviser at the European Medicines Agency quits suddenly. | BMJ (Clinical research ed.) 20120411 |
| Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France. | Pharmacoepidemiology and drug safety 20120401 |
| Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy. | Fundamental & clinical pharmacology 20120401 |
| In the wake of the Mediator scandal: some progress in France, but apathy at the European level. | Prescrire international 20120401 |
| Pressure-temperature state diagram for the phase relationships between benfluorex hydrochloride forms I and II: a case of enantiotropic behavior. | Journal of pharmaceutical sciences 20120301 |
| Appetite suppressant was probably responsible for 1300 deaths, study shows. | BMJ (Clinical research ed.) 20120209 |
| Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus. | PloS one 20120101 |
| Lessons from the Mediator scandal. | Prescrire international 20111201 |
| European drug regulator is being investigated by fraud agency. | BMJ (Clinical research ed.) 20111108 |
| [Benfluorex and valvular heart disease]. | Presse medicale (Paris, France : 1983) 20111101 |
| France toughens conflict rules. | Nature 20111011 |
| How can benfluorex-related heart valve disease be identified by echocardiography? | Archives of cardiovascular diseases 20111001 |
| Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease. | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20110901 |
| Screening for benfluorex and its major urinary metabolites in routine doping controls. | Analytical and bioanalytical chemistry 20110801 |
| Mediator: who's to blame? | Lancet (London, England) 20110611 |
| Mediator: who's to blame? | Lancet (London, England) 20110611 |
| Mediator: who's to blame? | Lancet (London, England) 20110611 |
| Benfluorex: analysis of a drug-related public health crisis. | Diabetes & metabolism 20110601 |
| [The French are wary of their drugs]. | Revue medicale suisse 20110525 |
| [Number of deaths attributable to benfluorex]. | Presse medicale (Paris, France : 1983) 20110501 |
| [Benfluorex (Mediator®), our vigilance in question]. | Presse medicale (Paris, France : 1983) 20110501 |
| Mitral and aortic valvular disease associated with benfluorex use. | The Journal of heart valve disease 20110501 |
| Benfluorex: the last chapter of drug-induced valvular heart disease? | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20110401 |
| Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry. | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20110401 |
| [Mediator, the police of the medication in question]. | Soins; la revue de reference infirmiere 20110401 |
| Mediator scandal rocks French medical community. | Lancet (London, England) 20110312 |
| [What were the indications for the Mediator in 1979?]. | Revue medicale suisse 20110209 |
| Drug scandal exposes French regulators to public ire. | Nature medicine 20110201 |
| Benfluorex: how many deaths? | Prescrire international 20110201 |
| Challenging special interest groups: whistleblowers may help. Help them! | Psychotherapy and psychosomatics 20110101 |
| [Letter on the article 'Number of deaths attributable to benfluorex']. | Presse medicale (Paris, France : 1983) 20110101 |
| French doctors demand to know why drug stayed on the market for so long. | BMJ (Clinical research ed.) 20101203 |
| Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. | Pharmacoepidemiology and drug safety 20101201 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Benfluorex: EU marketing authorisation finally withdrawn. | Prescrire international 20101001 |
| Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs. | Journal of pharmaceutical and biomedical analysis 20100921 |
| Restrictive organic mitral regurgitation associated with benfluorex therapy. | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20100801 |
| MR molecular imaging of aortic angiogenesis. | JACC. Cardiovascular imaging 20100801 |
| Benfluorex: yet more valve disorders. | Prescrire international 20100601 |
| Valvular heart disease associated with benfluorex. | Archives of cardiovascular diseases 20100501 |
| Benfluorex: increasing reports of valve disorders. | Prescrire international 20100201 |
| Benfluorex and unexplained valvular heart disease: a case-control study. | PloS one 20100101 |
| Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage. | Prescrire international 20090601 |
| Fenfluramine-like cardiovascular side-effects of benfluorex. | The European respiratory journal 20090301 |
| Effects of benfluorex-vitamin C supplementation on cutaneous capillaries of diabetic rats. | Cell biology international 20090301 |
| Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18 to 34-week, open-label, extension period. | Diabetes & metabolism 20090201 |
| A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance. | HIV clinical trials 20090101 |
| Valvular heart disease in a patient taking benfluorex. | Fundamental & clinical pharmacology 20061201 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study. | Diabetes care 20060301 |
| ATP-dependent and ATP-independent roles for the Rad54 chromatin remodeling enzyme during recombinational repair of a DNA double strand break. | The Journal of biological chemistry 20050318 |
| Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. | Molecular cell 20050304 |
| Modeling neuromuscular modulation in Aplysia. III. Interaction of central motor commands and peripheral modulatory state for optimal behavior. | Journal of neurophysiology 20050301 |
| On the mechanism of constitutive Pdr1 activator-mediated PDR5 transcription in Saccharomyces cerevisiae: evidence for enhanced recruitment of coactivators and altered nucleosome structures. | The Journal of biological chemistry 20041008 |
| Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. | The EMBO journal 20040721 |
| Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome. | HIV clinical trials 20040101 |
| A study on the release mechanism of drugs from hydrophilic partially coated perforated matrices. | Farmaco (Societa chimica italiana : 1989) 20030901 |
| Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. | Acta diabetologica 20030301 |
| [Valvular heart disease associated with benfluorex]. | Revista espanola de cardiologia 20030201 |
| Effects of benfluorex on fatty acid and glucose metabolism in isolated rat hepatocytes: from metabolic fluxes to gene expression. | Diabetes 20020801 |
| Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo. | Journal of diabetes and its complications 19990101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.